Cargando…
Modulating cGMP in heart failure by novel natriuretic peptides
Autor principal: | Burnett, John C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313442/ http://dx.doi.org/10.1186/1471-2210-9-S1-S8 |
Ejemplares similares
-
A novel pathway of cGMP
por: Kuhn, Michaela, et al.
Publicado: (2011) -
M-atrial natriuretic peptide and nitroglycerin in experimental acute hypertensive heart failure: differential actions of two cGMP activating therapeutics
por: McKie, Paul M, et al.
Publicado: (2013) -
Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011) -
The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009) -
Role of cGMP in fat and metabolism
por: Pfeifer, Alexander, et al.
Publicado: (2013)